Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with the Hemasite vascular prosthesis.

B Viron1, B Lukacs, C Michel

  • 1Services de Néphrologie A, Hopital Tenon, Paris.

Artificial Organs
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Voiding urethrocystoscopy: A new concept for benign prostatic obstruction characterization.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2019
Same author

Perioperative and economic analysis of surgical treatments for benign prostatic hyperplasia: A study of the French committee on LUT.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2017
Same author

[Medicoeconomic aspects of benign prostatic hyperplasia medical treatment].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Evaluation of postoperative symptoms after Greenlight™ photovaporization of the prostate through a dedicated questionnaire].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015

The Hemasite vascular access device shows promise for hemodialysis patients with failed previous accesses. This no-needle device reduced the need for surgical interventions, despite experiencing thromboses.

Area of Science:

  • Nephrology
  • Vascular Surgery

Background:

  • Patients undergoing hemodialysis often experience vascular access failures.
  • Repeated failures necessitate frequent surgical interventions, increasing patient morbidity.

Purpose of the Study:

  • To evaluate the 3-year clinical experience with the no-needle Hemasite vascular prosthesis in hemodialysis patients.
  • To assess the efficacy of Hemasite in reducing surgical interventions for vascular access.

Main Methods:

  • A cohort of 10 hemodialysis patients with a history of multiple vascular access failures received Hemasite implants.
  • Follow-up included monitoring for thromboses, interventions (urokinase infusion, thrombectomy, surgery), and calculating intervention rates.

Main Results:

Related Experiment Videos

  • Over 182 months of follow-up, 30 thromboses occurred in 9 of 10 patients not on antiplatelet therapy.
  • Hemasite required declotting 12 times with urokinase and 12 times via thrombectomy.
  • The rate of surgical intervention decreased significantly from 0.18 to 0.027 interventions per patient per month post-implantation.
  • Conclusions:

    • The Hemasite no-needle vascular prosthesis can be a viable option for hemodialysis patients with challenging vascular access.
    • Implantation of Hemasite led to a substantial reduction in the rate of surgical interventions required for access maintenance.